Download PDF Flyer
Impact Factor Current: 2.218
5 - Year: 2.379

Current Gene Therapy

Editor-in-Chief

ISSN (Print): 1566-5232
ISSN (Online): 1875-5631

Latest Issue: Volume 19 , Issue 3 , 2019

Back Journal Home
Impact Factor
Web of Science Impact Factor

Current: 2.218
5 - Year: 2.379

Ranking & Category

  • 115th of 171 in Genetics & Heredity

Topics Covered

1 Topics

View
Covered Diseases

0 Diseases

View

Aims & Scope

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Abstracted/Indexed in


Science Citation Index Expanded™, SciSearch®, Journal Citation Reports/Science Edition, InCites, Index to Scientific Reviews®, Current Contents® - Life Sciences, Biotechnology Citation Index®, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, MEDLINE/PubMed/Index Medicus, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts Service/SciFinder, ProQuest, ChemWeb, Google Scholar, EMBiology, PubsHub, Index Copernicus, Genamics JournalSeek, Cabell's Directory, MediaFinder®-Standard Periodical Directory, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.

Announcements
New eBook
Probing intracellular regulation
You can view the contents of this
eBook [here] 
Endorsement(s)

"Timely reviews, extensive, in-depth coverage of all of gene therapy; a great way to get and stay up-to-date."

Donald Kohn
Keck U.S.C. School of Medicine, USA

Authors' Comments

In my opinion contributing for Bentham Science was the best that I had experienced till now. You were too much supporting and speedy. I can't believe that the acceptance process had been performed in only 2 months. That is incredible.

Touba Eslaminejad
(Kerman University of Medical Sciences kerman, kerman, Iran.)

Has contributed: Glioblastoma Targeted Gene Therapy Based on pEGFP/p53-Loaded Superparamagnetic Iron Oxide Nanoparticles.

© 2019 Bentham Science Publishers